<scp>GluN2C</scp> selective inhibition is a target to develop new antiepileptic compounds-Reference-Cited by-同舟云学术

GluN2C selective inhibition is a target to develop new antiepileptic compounds

Published:2022-09-11 Issue:11 Volume:63 Page:2911-2924
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Gataullina Svetlana¹^ORCID,Galvani Gilles²,Touchet Sabrina³,Nous Caroline⁴,Lemaire Éric²,Laschet Jacques⁵,Chiron Catherine⁶⁷^ORCID,Dulac Olivier²^ORCID,Dossi Elena⁸,Brion Jean‐Daniel⁹,Messaoudi Samir⁹,Alami Mouad⁹,Huberfeld Gilles⁸¹⁰^ORCID

Affiliation:

1. Service D'explorations Fonctionnelles Multidisciplinaires, Centre de médecine du sommeil Antoine Béclère Hospital, APHP, Université Paris Saclay Clamart France

2. AdPueriVitam (APV) Antony France

3. L2CM, CNRS UMR 7053 Université de Lorraine Nancy France

4. Institut de la Vision, UFR Sciences et Technologies Paris France

5. LCA Laschet Consult & Analysis SAS Angerville France

6. INSERM U1141 Paris France

7. Neuropediatrics Department Necker Hospital, APHP Paris France

8. Center for Interdisciplinary Research in Biology, Collège de France, CNRS UMR 7241, INSERM U1050 Université PSL Paris France

9. CNRS UMR 8076, BioCIS Université Paris‐Saclay Châtenay‐Malabry France

10. Neurology Department Hôpital Fondation Adolphe de Rothschild Paris France

Funder

Bpifrance

Publisher